Bristol Myers Squibb (BMY)

EBITDA Growth

55.61%

Quarterly · Period ending:

BMY logo

BMY EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported55.61%
BMY Quarterly EBITDA YoY % (12.04% → 55.61%)
High-resolution chart · PNG

BMY ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb EBITDA Growth — Quarterly
Period endingEBITDA Growth
55.6133%
-5.182%
12.8577%
-3.5198%
-25.7552%
152.3075%
-42.7256%
-1.6282%
-3.7175%
-255.9869%
-4.7069%
-4.7881%
-5.789%
19.3605%
-1.8067%
-2.2256%
5.6366%
-17.1861%
164.2722%
-0.8749%
1.1669%
118.9744%
-634.3434%
204.1064%
119.6325%
15.5424%
-19.6522%
-27.2306%
187.6217%
11.4837%
82.3467%
67.4419%
-53.8511%
-10.2599%
-24.1987%
-16.823%
-10.8185%
24.3902%
528.866%
50.5737%
809.8958%
9.9813%
-403.125%
-3.1624%
-68.4729%
36.3095%
-91.2965%
12.069%
-20.8062%
25.5069%
44.5609%
202.7559%
-38.3814%
-57.5634%
-58.6001%
-151.9427%
-38.4615%
11.0664%
11.4943%
7.4725%
11.7355%
18.8995%
59.7101%
1.5059%
4.2504%
18.2461%
-53.5249%
28.2546%
17.0027%
-7.6421%
155.3899%
28.1393%
40.3774%
52.9471%
93.7778%
58.5756%
-16.3378%
-12.4234%
-58.1395%
-42.523%
-6.4254%
-8.8517%
-13.3065%
-15.1064%
-0.3679%
-6.9733%
-11.8692%
-11.0971%
-5.428%
3.137%
31.7416%
25.574%
38.9749%
-21.5015%
-37.7259%
-23.4081%
-37.5227%
-7.2423%
-4.2969%
-3.7923%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.